Global Pharma Selects Kneat to Digitize Computer System Validation
09 October 2024 - 8:04AM
kneat.com, inc. (TSX: KSI) (OTC: KSIOF), a leader
in digitizing validation and quality processes, is pleased to
announce that a global pharmaceutical company has signed a
three-year Master Services Agreement with Kneat to digitize its
validation processes.
Headquartered in Germany with over 11,000 employees across more
than a dozen facilities, the company is a trusted maker of
household consumer health care brands and generic and specialty
pharmaceuticals for customers in over 120 countries. The company
selected Kneat as their corporate solution after a comprehensive
evaluation process. The company’s goal is to enhance the
efficiency, accuracy, and compliance of complex validation
processes across its global operations, starting with Computer
System Validation (CSV).
“This announcement further demonstrates Kneat’s leadership
position across the full Validation spectrum,” said Eddie Ryan,
Chief Executive Officer of Kneat. “We look forward to supporting
this company to achieve harmonization for all their validation
processes on a single platform.”
About Kneat
Kneat Solutions provides leading companies in highly regulated
industries with unparalleled efficiency in validation and
compliance through its digital validation platform Kneat Gx. We
lead the industry in customer satisfaction with an unblemished
record for implementation, powered by our user-friendly design,
expert support, and on-demand training academy. Kneat Gx is an
industry-leading digital validation platform that enables highly
regulated companies to manage any validation discipline from
end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified,
fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple
independent customer studies show a 40% or more reduction in
validation cycle times, nearly 20% faster speed to market, and 80%
reduced changeover time.
Cautionary and Forward-Looking Statements
Except for the statements of historical fact contained herein,
certain information presented constitutes “forward-looking
information” within the meaning of applicable Canadian securities
laws. Such forward-looking information includes, but is not limited
to, the relationship between Kneat and the customer, Kneat’s
business development activities, the use and implementation
timelines of Kneat’s software within the customer’s validation
processes, the ability and intent of the customer to scale the use
of Kneat’s software within the customer’s organization and the
compliance of Kneat’s platform under regulatory audit and
inspection. While such forward-looking statements are expressed by
Kneat, as stated in this release, in good faith and believed by
Kneat to have a reasonable basis, they are subject to important
risks and uncertainties. As a result of these risks and
uncertainties, the events predicted in these forward-looking
statements may differ materially from actual results or events.
These forward-looking statements are not guarantees of future
performance, given that they involve risks and uncertainties.
Kneat does not undertake any obligation to release publicly
revisions to any forward-looking statement, except as may be
required under applicable securities laws. Investors should not
assume that any lack of update to a previously issued
forward-looking statement constitutes a reaffirmation of that
statement. Continued reliance on forward-looking statements is at
an investor’s own risk.
For further information:
Katie Keita, Kneat Investor RelationsP: + 1 902-450-2660
E: investors@kneat.com
Kneat Com (TSX:KSI)
Historical Stock Chart
From Oct 2024 to Nov 2024
Kneat Com (TSX:KSI)
Historical Stock Chart
From Nov 2023 to Nov 2024